Teva Pharmaceutical Industries (TEVA) Reports Q3 Earnings: What Key Metrics Have to Say

By Yahoo! Finance | Nov 6, 2024 at 09:30 AM EST

Teva Pharmaceutical Industries reported $4.33 billion in revenue for the quarter ended September 2024, up 12.5% YoY, with an EPS of $0.69. The company exceeded revenue and EPS estimates, showcasing growth in various geographic markets and product segments.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.